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Relationship of glomerular hypertrophy and sclerosis: Studies in SV4O
transgenic mice. We previously described the development of glomer-
ulosclerosis in mice transgenic for large T-antigen, a gene whose in vitro
expression markedly increases proliferation of cultured cells. In the
current study we sought to determine the effect of unilateral nephrec-
tomy on these sclerosis-prone animals which have a genetically defined
potential for increased renal growth. In comparison with sham nephrec-
tomy animals, nephrectomized transgenic female mice had significantly
larger kidneys, larger glomeruli (5886 s2 npx vs. 3796 2 sham), more
cells per glomerulus and more severe glomerulosclerosis. Nephrecto-
mized transgenic male animals had variable increases in kidney size, no
significant increase in glomerular size (4750 s2 npx vs. 4502 sham) or
cellularity, and no worsening of glomeruloscierosis. In non-transgenic
female animals nephrectomy induced an increase in kidney size but not
in glomerular size (2640 2 npx vs. 2625 2 sham) and failed to induce
glomerular lesions. A close correlation (r = 0.91) was found between
glomerular size and severity of glomerulosclerosis in these animals.
This finding supports the hypothesis that a pathophysiologic link exists
between glomerular enlargement and glomeruloscierosis. We also
found that increases in total kidney size and glomerular size did not
consistently parallel each other, that is, renal hypertrophy may occur
without an increase in glomerular size. This finding suggests that total
kidney growth and glomerular growth may be independently regulated
or may have different thresholds for activation following unilateral
nephrectomy.
Subtotal nephrectomy models have been utilized extensively
as a tool to understand the progressive decline in renal function
which may occur following renal injury [1, 2]. A prominent
feature of these models is the compensatory hypertrophy and
glomerulosclerosis which occur following nephrectomy. Renal
and/or glomerular hypertrophy and glomerulosclerosis also
occur in the setting of diabetic nephropathy [3], following
induction of Goldblatt hypertension in diabetic animals [4], and
in animals maintained on a high protein diet [5]. The close
association between hypertrophy and the development of gb-
merulosclerosis suggests that hypertrophy per se may play a
significant and perhaps causal role in the pathogenesis of
glomerulosclerosis [1, 61.
One question which current models has left unanswered is
why some humans and animals develop glomerubosclerosis
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following nephrectomy or the onset of diabetes mellitus while
others do not [7—12]. If hypertrophy is important in the patho-
genesis of gbomerubosclerosis, it is possible that susceptibility to
glomerubosclerosis may be dependent, at least in part, on the
regulation of renal and/or glomerular enlargement. The genetic
background of an animal could play a role in defining the
magnitude of the hypertrophic response and thus the induction
and severity of subsequent gbomerular damage. We previously
described a model of progressive glomerubosclerosis in a line of
mice transgenic for the gene encoding large T-antigen (SV Tag
{SV4OE} Bri7) which is found in the early region of simian virus
40 (SV4O) [13, 14]. At birth these mice appear normal and by
four weeks of age have either no or a relatively mild degree of
glomerulosclerosis. As the animals age, some develop more
severe glomerulosclerosis. Since production of large T-antigen
by many types of cultured cells, including gbomerular cells [15],
markedly enhances their proliferative potential [16—18] we
theorized that gbomerulosclerosis in the SV4O transgenic mice
may be a consequence of dysregulation of glomerular cell
proliferation and/or extracellubar matrix synthesis induced by
local expression of large T-antigen.
These animals were used to test the postulate that the
addition of a hypertrophic stimulus (that is, nephrectomy) to
animals with a pre-existing defect in the control of renal growth
could lead to an altered hypertrophic response. Further, if such
a response is significant in the pathogenesis of gbomeruboscle-
rosis, it should be possible to demonstrate an association
between the extent of hypertrophy and the severity of glomer-
uloscberosis.
Methods
Animals
Transgenic (SV Tg {SV4OE} Br17) and non-transgenic control
animals were derived as previously described [13]. At five
weeks of age animals were randomly assigned to undergo either
unilateral nephrectomy or sham nephrectomy. The mice were
anesthetized with an intraperitoneal injection of avertin (tribro-
moethanol/tertiary amyl alcohol, 2: 1, wt/vol). The left kidney
was removed through a midline abdominal incision and the
peritoneum and skin closed with 5-0 silk. Animals were allowed
free access to standard laboratory rodent chow and water.
Animals were weighed weekly. When the mice were 14 weeks
of age (9 weeks following nephrectomy) the animals were again
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anesthetized, bled with cardiac puncture, and their heart,
kidney(s), liver and spleen removed. The organs were blotted
dry and weighed. Two female animals (one nephrectomy, one
sham) had choroid plexus tumors clinically evident by bulging
cranium and weight loss during the week preceding their
sacrifice. These animals were not included in the organ size data
presented below. Portions of each organ were placed in Car-
noy's fixative or homogenized in buffer (150 mi NaCI, 50 mM
Tris-HCL pH 8.0, 5 mi EDTA, 100 sg/ml PMSF). Homoge-
nates were stored at —70°C until utilized. The homogenates
were utilized in Western blots described below.
A second group of five-week-old transgenic animals under-
went nephrectomy via a left flank incision. These animals were
allowed free access to food and water then sacrificed at either
six or fourteen days following nephrectomy. The left and right
kidney were homogenized in the above described buffer.
Urine protein and creatinine determination
Urine protein concentration was determined by the method
of Bradford [19] using an albumin standard and reagents from
Bio-Rad (Rockville Center, New York, USA). Urine creatinine
concentration was determined using a quantitative colorimetric
method from Stanbio Lab Inc. (San Antonio, Texas, USA).
Light microscopy
Kidneys were embedded in methacrylate and stained with
PAS, H&E, and silver methenamine. Glomerular and tubular
lesions were scored as detailed in the legend to Figure 2. The
examiner was blinded to the animal group. Liver and spleen
sections were fixed in Carnoy's fixative, embedded in paraffin,
and stained with PAS and H&E.
Glomerular size and nuclear counts
Silver-stained sagittal sections of kidney were scanned under
light microscopy using a serpentine movement from cortex to
medulla so as to assure equal sampling of the kidney and to
avoid evaluating the same glomerulus twice. The glomerular
tufts of fifty consecutively encountered glomeruli were traced
and the glomerular cross-sectional area determined using a
digitizing graphic pad and the Halo program (Media Cybernet-
ics, Silver Spring, Maryland, USA).
Nuclei in twenty-five consecutively encountered glomeruli
were counted on the projected images of H&E stained sections
using a video camera and monitor. The reproducibility of the
cell counts was demonstrated by two separate evaluations of
one section in which 28.7 10.9 nuclei/cross section (mean
SD) were counted on the first and 27.2 10.7 nuclei/cross
section counted on the second evaluation. Glomerular nuclear
cross sectional area was also measured to evaluate the possi-
bility that erroneous results of nuclear counts occurred because
of a large increase in nuclear size following nephrectomy.
Nuclear size was determined using the digitizing graphic pad
described above. Fifty nuclei with well defined contours in
randomly chosen glomeruli were sampled from nephrectomized
and sham nephrectomy transgenic female animals. No signifi-
cant difference was found between the mean nuclear size in the
two groups. In addition, no shift was present in the nuclear
profile size distribution of the nephrectomized or sham nephrec-
tomy animals.
Table 1. Up/Ucr
Control
Transgenic
female
Transgenic
male
Npx 0.6 0.2 4.0 1.9 3.8 2.5
Sham 0.7 0.4 3.2 2.1 4.7 2.8
Data expressed as the ratio of urine protein (g/ml) and urine
creatinine (.g/ml) SD.
Western blots
The protein concentration of tissue homogenates was deter-
mined using an albumin standard and reagents from Bio-Rad
(Rockville Center, New York, USA). One hundred microliter
aliquots of kidney and 200 g aliquots of spleen and liver were
subjected to SDS gel electrophoresis [20] using a 7.5% gel
which was then transferred to nitrocellulose. The homogenate
(10 p.g) from a glomerular mesangial cell line derived from the
SV Tag 188 line of mice was used as a positive control [15].
Blots were fixed in 10% acetic acid/50% methanol for five
minutes, washed twice with distilled water then blocked for one
hour with 5% milk powder (Carnation, Los Angeles, California,
USA) in Tris buffered saline (TBS:500 m'vi NaCI, 20 mM
Tris-HC1 pH 7.5). Blots were washed twice in TBS with 0.5%
Tween-20, and twice in TBS. The first antibody incubation was
for two hours with 5 g/ml of SV4O T Ag (Ab-2), a monoclonal
antibody directed against the 94,000 dalton SV4O large T-
antigen (Oncogene Science, Inc., Manhasset, New York, USA)
in a 2% milk/TBS solution. Blots were washed again then
incubated for one hour in 2% milk/TB S with a 1:2000 dilution of
alkaline phosphatase conjugated goat anti-mouse IgG (Jackson
Immunoresearch Laboratories, Inc., West Grove, Pennsylva-
nia, USA), washed, rinsed in alkaline phosphatase buffer (100
mM Tris-HC1, pH 9.5, 100 mM NaCl, 5 mrs MgCl), then
developed in alkaline phosphatase buffer with NBT/BCIP sub-
strates (nitro blue tetrazolium, 5-bromo-4-chloro-3-indolyl-
phosphate; Promega, Madison, Wisconsin, USA).
Results
General
Following surgery the animals were allowed free access to
standard chow and water. The experiment was terminated
when the animals were fifteen weeks old. During week fourteen
one transgenic male (sham group) and one transgenic female
(nephrectomy group) died. These deaths appeared to be due to
choroid plexus tumors which these animals characteristically
develop between 12 and 20 weeks of age.
Urine samples obtained prior to the sacrifice of each animal
were assayed for protein and creatinine. The results expressed
as urine protein/urine creatinine (Up/U) are provided in Table
1. With only one exception (ratio 1.3) all the non-transgenic
animals had a UP/UC below 1.0. In contrast, the ratio exceeded
1.0 in all transgenic animals. There was no significant difference
in the amount of proteinuria found in the transgenic animals
subjected to nephrectomy or sham nephrectomy. There was
also no significant difference in the Up/Ucr ratios of the
transgenic male and female animals.
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Table 2.
# MS SC SY/CR %OBS TP
Transgenic female
NPX A2
B2
D2
E2
F2
G2
M2
++
++
++
++
++
++
+++
-i-++
+++
+++
+++
++-t-
+++
++
2
2
3
0
2
4
0
++
+
++
+
+i-
+
+
Sham 12
J2
N2
02
P2
Q2
+
+
0
+
0
+
+
+
0
+
0
0
0
0
0
0
0
0
+
+
0
+
0
+
Transgenic male
NPX Ml
M4
M5
M6
M8
++
+
+
+
+--
+++
+
+
+
+
3
0
0
0
I
++
+
+
+
+
Sham M9
M10
Mu
M12
M13
Ml6
+
++
+
+
+
+
++
-i-+
+
+
+
+
0
2
0
0
0
0
++
+
+
+
+
+
# = number assigned each animal.
MS SC = mesangial sclerosis, scoring system: + affecting only few
glomeruli (<20%) and a small number of mesangial spaces; + +
affecting more than 20% of glomeruli and a larger number of mesangial
spaces; + + + diffuse with all mesangial spaces in all glomeruli involved
to a moderate degree; + + + + diffuse with all mesangial spaces in all
glomeruli severely involved.
SY/CR = Synechiae/Crescents, scoring system: + present in less
than 10% of glomeruli; + + present in 10—20% of glomeruli; + + +
present in 20—50% of glomeruli; ++++ present in over 50% of
glomeruli.
%Obs = percentage obsolescent glomeruli. TP = tubular prolifera-
tion, scoring system: + segmental lesions with modest amounts of
proliferation; ++ segmental lesions with more marked amount of
proliferation; ÷ + + more diffuse lesions with marked amounts of
proliferation.
Light microscopy
The severity of renal lesions was determined by assessment
of the amount of mesangial sclerosis, the presence of synechiae/
crescents, the number of obsolescent glomeruli and the degree
of tubular proliferation. Scoring of the lesions was determined
as described in the legend to Table 2. No glomerular lesions
were noted in any of the nephrectomy (N = 8) or sham
nephrectomy (N = 6) control animals. As indicated in Table 2,
modest degrees of glomerular damage were present in both the
female and male sham nephrectomy groups. With the exception
of one animal, Ml, the glomerular lesions of nephrectomized
males were not different from those of sham nephrectomy
animals.
The response of female and male transgenic animals sub-
jected to nephrectomy was quite different. The nephrectomized
transgenic females had an increase in the amount of mesangial
sclerosis, the number of synechiae, and in the number of
obsolescent glomeruli.
I 0)5
I I E
CF TGF TGM
Spleen/TBW
If If f
CF TGF TGM CF TGF TGM
Fig. 1. Organ/total body weight (TBW) ratios. The mean SD of total
body weights for control female (CF), transgenic female (TGF), and
transgenic male (TGM) are given in the top panel for nephrectomized(•) and sham nephrectomy animals (D). OrganITBW ratios are pro-
vided in the lower panels. Significant differences (P < 0.05 by unpaired
t-test) existed between the nephrectomy and sham nephrectomy ani-
mals only in the following: Kidney/TBW: CF, TGF, TOM; Liver/TBW:
TGF; Spleen/TBW: TGF.
Organ size
There was no significant difference between the total body
weights of the nephrectomy and sham nephrectomy animals in
any of the three groups, as indicated in Figure 1. The weight of
each organ is expressed as the ratio of organ weight (mg) to total
body weight (g). As expected, there was a significant increase in
kidney weight between nephrectomy and sham nephrectomy
animals in each group. There was no difference in heart/TBW
ratio in any group. This speaks against the presence of signifi-
cant hypertension which would be expected to induce cardiac
hypertrophy.
There was an unexpected increase in the liver and spleen
total body weight ratios in the nephrectomized transgenic
females. No significant increase in spleen or liver total body
weight ratios were present in the control female and nephrec-
tomized male groups. There were no significant abnormalities
noted in any of the liver and spleen sections by light micros-
copy. In addition, there were no histologic differences noted
between the livers and spleens from the nephrectomized trans-
genic females when compared to animals from any other group.
The percent increase in kidney weight between the nephrec-
tomized and sham nephrectomy animals was determined in
order to assess whether the renal hypertrophic response dif-
fered between groups. The percentage increase (npx weight —
mean sham weight/mean sham weight) was calculated for each
nephrectomized animal. The increase was significantly greater
in the transgenic females when compared to non-transgenic
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Fig. 2. Mean glomerular cross-sectional area (2)The cross sectional
area of fifty consecutively encountered glomeruli were measured for
each control female (CF), transgenic female (TGF), and transgenic male
(TGM). The mean of that determination (in 2) for each animal is
plotted for each nephrectomized (•) and sham nephrectomy (0)
animal. The mean SD for each group as a whole is as follows: CF:
2640 843 npx, 2625 788 sham, P = 0.8; TGF: 5886 1886 npx, 3796
1499 sham, P < 0.001; TGM: 4750 1904 npx, 4502 1550 sham,
P = 0.14.
females (60% 15 vs. 36% 6, P < 0.001 by unpaired t-test).
The increase in weight for nephrectomized transgenic males
varied too widely (33% 30) to allow meaningful comparison.
Glomerular cross-sectional area
Since the bulk of renal hypertrophy which occurs following
nephrectomy involves an increase in tubular size [2], we
questioned whether the degree of glomerular enlargement cor-
related with the increase in kidney weight.
The effect of unilateral nephrectomy on glomerular enlarge-
ment was assessed by measuring the cross sectional area of fifty
glomeruli in each animal (Fig. 2). There was a significant
increase in mean glomerular size in the nephrectomized trans-
genic female animals when compared to transgenic female sham
nephrectomy animals (5886 1886 js2 vs. 3796 1497 s2, mean
SD, P < 0.001 by unpaired t-test). In contrast, despite
increases in total kidney weight there was no significant in-
crease in mean glomerular cross-sectional area in either the
control female or the transgenic male animals subjected to
nephrectomy. Thus, in transgenic males and normal female
animals renal hypertrophy occurred without concomitant gb-
merular enlargement, whereas in transgenic females there was
an increase in both glomerular and renal size.
To determine if the difference in mean gbomerular area was a
function of a diffuse increase in gbomerular size or reflected the
development of hypertrophy in a sub-population of glomeruli
we plotted the profile size distribution of glomerular cross-
sectional area for each group. There was a shift to the right of
the frequency distribution curve for nephrectomized transgenic
female animals indicating a diffuse increase in glomerular size in
Glomerular area, x 1000
Fig. 3. Profile size distribution of glomerular cross-sectional areas.
The cross sectional area of fifty consecutively encountered glomeruli in
each animal was determined as described in Methods. The number of
gbomeruli in each 1000 2 size increment were determined for each
animal. The mean number of gbomeruli and SEM for each size increment
is plotted for both nephrectomy (•) and sham nephrectomy (0)
animals.
this group (Fig. 3). The control female animals anu the trans-
genic male animals exhibited nearly identical profile size distri-
butions in the nephrectomy and sham nephrectomy groups.
If glomerular cell proliferation contributed to the observed
increase in gbomerular size one could see an increase in the
number of cells per glomerular profile. As shown in Figure 4
there was a significant increase in the number of nuclei per
glomerular profile in the nephrectomized transgenic female
animals compared to sham control animals (40 15 vs. 31 12,
P < 0.001). In contrast, the number of nuclei per cross section
was nearly identical in the nephrectomized and sham nephrec-
tomy animals in both the control female and transgenic male
groups.
Association of glomerular size and sclerosis
If glomerular growth is important in the pathogenesis of
glomeruloscierosis a correlation should exist between glomer
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Control female
20 40 6 80
20 40 60 80
Transgenic male/
20 40 60 80
# Nuclei/cross section
Fig. 4. Frequency distribution of nuclei per glomerular cross section.
The number of nuclei of twenty-five consecutively encountered glomer-
uli were determined as described. The number of nuclei in each
increment of 10 were determined for each animal. The mean number of
glomeruli with the given number of nuclei is plotted for both nephrec-
tomy (•) and sham nephrectomy (0) animals.
ular size and the severity of glomeruloscierosis. The association
between glomerular size and the severity of sclerosis for
individual experimental animals is displayed in Figure 5. A
close correlation between glomerular size and sclerosis was
evident (r 0.91). With few exceptions, the animals with mean
glomerular cross-sectional area of <3500 2 had no or minimal
sclerosis, animals with a mean glomerular cross-sectioral area
between 3500 and 5000 t2 had sclerosis of moderate severity
and animals with a mean glomerular cross-sectional area of
50jJ0 2 had the most severe sclerosis.
T-antigen
Kidneys, liver and spleen removed from the transgenic
animals at the time of sacrifice (9 weeks post-nephrectomy)
were assessed for the presence of large T-antigen using Western
blots of tissue homogenates. Large T-antigen was present in the
kidneys of all transgenic animals with no apparent difference
between the levels of protein present in the female or male
animals in either the nephrectomy or sham nephrectomy groups
(Fig. 6). Large T-antigen was also present in the spleen of
Sclerosis
Fig. 5. Glomerular size and sclerosis. The mean glomerular cross-
sectional area is plotted for each animal as a function of sclerosis
severity. The numerical severity of sclerosis was determined by adding
the number of + 's in the sclerosis and synechiae/crescent columns
given in Table 2. Values are given for nephrectomized transgenic
females (I) and males (, sham nephrectomy transgenic females (0)
and males (0), and normal females subjected to either nephrectomy (A)
or sham nephrectomy (is).
Fig. 6. Large T-antigen in kidneys of transgenic animals. Western blot
of homogenates of transgenic mouse kidneys using a monoclonal
antibody against large T-antigen. The first lane is a homogenate from a
large T-antigen producing line of glomerular mesangial cells derived
from this line of transgenic mice. Other lanes are as follows: nephrec-
tomized transgenic females (A—D), sham nephrectomy transgenic fe-
males (E, F), normal mouse kidney (0), nephrectomized transgenic
males (H—L), sham nephrectomy transgenic male (M—O). Arrow indi-
cates the location of the 93,500 dalton molecular weight marker. The
large T-antigen protein appears as a doublet.
transgenic animals in all groups (male/female and nephrectomy/
sham; Fig. 7). Large T-antigen was not detectable in the liver
from any animal.
We examined kidneys in a second group of nephrectomized
male and female transgenic animals for the presence of T-
antigen at six and fourteen days following nephrectomy. As
shown in Figure 8 there was heterogeneity in the amount of
large T-antigen present in kidneys of five-week-old mice. There
appeared to be a consistent increase in the amount of large
T-antigen present in the remaining kidney six (data not shown)
and fourteen days post-nephrectomy when compared to that
present in the kidney removed initially. There was no apparent
difference in the increment of T-antigen present between the
nephrectomized male and female animals.
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M F
Fig. 7. Large T-antigen in sp!eens of transgenic animals. Western blot
of homogenates of transgenic mouse spleens. Homogenates are from
four male (M) (one sham followed by three nephrectomized) and four
female (F) (one sham followed by three nephrectomized).
F M
Fig. 8. Large T-antigen in kidneys of transgenic animals at the time of
nephrectomv and fourteen days later. Homogenates from the left
kidney removed at the time of nephrectomy are run adjacent (to the left)
to homogenate from right kidney removed 14 days later in four female
(F) and four male (M) transgenic animals. There appears to be an
increase in the amount of large T-antigen present at day 14 compared to
day 0 in almost all of the animals.
Discussion
Glomerular enlargement has been found in association with
glomerulosclerosis in a number of clinical and experimental
settings [1—71. If increased glomerular size is important in the
pathogenesis of glomerulosclerosis, it is possible that an ani-
mal's susceptibility to glomeruloscierosis may at least in part be
dependent on its regulation of glomerular enlargement. In order
to explore this postulate we utilized an animal model with a
genetically defined propensity for enhanced renal growth and
employed unilateral nephrectomy as a second stimulus for renal
growth. As previously described [131, mice transgenic for the
gene encoding large T-antigen (SV Tag {SV4OE}Bri7) appear
normal at birth and have either no or a relatively mild degree of
glomerulosclerosis at four weeks of age. As is evident in the
animals subjected to sham nephrectomy in this study, and as
previously described [13], some of these transgenic animals
develop more severe glomerulosclerosis as they age.
Since the production of large T-antigen by cultured cells leads
to an enhanced proliferative potential [15—18], we reasoned that
the combination of large T-antigen expression in the kidney plus
the growth stimulus of unilateral nephrectomy might combine
to yield an altered glomerular and/or renal hypertrophic re-
sponse. Further, if the magnitude of the hypertrophic response
is important in defining the severity of glomerulosclerosis, we
anticipated a positive correlation would exist between the
amount of hypertrophy and the severity of sclerosis [19, 20].
The major findings of this study include: (1) a close correla-
tion between glomerular size and the severity of glomerulo-
sclerosis, (2) dissociation of glomerular growth and renal
growth, and (3) disparity of response to nephrectomy of trans-
genic male and female animals.
There was a broad range of mean glomerular sizes in animals
studied. Examining the groups as a whole demonstrated a close
correlation between glomerular size and severity of sclerosis (r
= 0.91). Our study did not focus on the time course of
glomerular enlargement and sclerosis and thus we are not able
to assess whether glomerular enlargement in this model pre-
ceded the development of glomerulosclerosis. Other studies
which have addressed this issue in diabetics and in animals
subjected to subtotal nephrectomy found that glomerular en-
largement precedes the development of glomerular sclerosis
[21, 221. These findings are consistent with the hypothesis that
glomerular enlargement may play a significant role in the
cascade of events which leads to glomerulosclerosis.
Several other lines of evidence combine to support the strong
association between glomerular hypertrophy and glomerulo-
sclerosis. First is the consistent finding of glomerular enlarge-
ment in many human diseases and experimental models of
glomeruloscierosis [1—7]. Second, factors known to modulate
the severity of glomerular sclerosis also modify glomerular size.
Glomerular cross-sectional area varies directly with dietary
protein content [23]. Also, treatment of nephrectomized rats
with angiotensin converting enzyme inhibitors is associated
with significantly lower glomerular volume [241. While the
effects of angiotensin converting enzyme inhibitors on altering
glomerular hemodynamics has been the major focus of recent
attention, it is also possible that this drug exerts it beneficial
effect by limiting mesangial cell hypertrophy and proliferation
induced by angiotensin II [25].
Multiple factors could contribute to the development of
glomerular enlargement. These include increased glomerular
pressures which could dilate the glomerular capillary loops,
proliferation of resident glomerular cells, and an increase in the
amount of extracellular matrix material within the glomerulus.
In the transgenic mice we anticipated that at least a portion of
the glomerular enlargement would be due to hyperplasia of
glomerular cells possibly because of large T-antigen stimulated
proliferation. This possibility is supported by the finding of
increased glomerular cellularity in the enlarged glomeruli of the
nephrectomized transgenic female mice. The finding of glomer-
ular hypercellularity only in the most severely sclerotic animals
(nephrectomized transgenic females) suggests that glomerular
hypercellularity may play a significant role in the pathogenesis
of glomerulosclerosis. Other, as yet undefined, factors appear
to contribute to the glomerular hypertrophy found in transgenic
animals subjected to sham nephrectomy since glomeruli in
these animals were larger than those in non-transgenic control
animals despite equivalent numbers of glomerular cells.
The second significant finding of this study was the demon-
stration of a dissociation between whole kidney and glomerular
hypertrophy. Compensatory hypertrophy is conventionally
thought to involve all component parts of the nephron [21. Our
data indicate, however, that glomerular enlargement does not
invariably parallel total renal hypertrophy. This finding is not
without precedent. Vancura and coworkers in 1970 found no
increase in glomerular size in mice following nephrectomy [261.
In addition, Grond and coworkers described differing suscepti-
I H I
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may add considerably to our understanding of the pathogenesis
of glomeruloscierosis.
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bility to glomerular sclerosis in Wistar and PVGIc rats [10].
While both strains of rats evidenced comparable increases in
glomerular filtration rate and renal plasma flow following uni-
lateral nephrectomy, glomerular enlargement and focal and
segmental glomeruloscierosis occurred only in the Wistar rats.
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and demonstrates that qualitatively and quantitatively dissimi-
lar renal hypertrophic responses may occur following unilateral
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